Skip Navigation
Genetics Home Reference: your guide to understanding genetic conditions
http://ghr.nlm.nih.gov/     A service of the U.S. National Library of Medicine®

DICER1 syndrome

Reviewed May 2013

What is DICER1 syndrome?

DICER1 syndrome is an inherited disorder that increases the risk of a variety of cancerous and noncancerous tumors, most commonly certain types of tumors that occur in the lungs, kidneys, ovaries, and thyroid (a butterfly-shaped gland in the lower neck). Affected individuals can develop one or more types of tumors; even members of the same family can have different types. However, the risk of tumor formation in individuals with DICER1 syndrome is only moderately increased compared with tumor risk in the general population; most individuals with genetic changes associated with this condition never develop tumors.

People with DICER1 syndrome most commonly develop pleuropulmonary blastoma, which is characterized by tumors that grow in lung tissue or in the outer covering of the lungs (the pleura). These tumors occur in infants and young children. Pleuropulmonary blastoma is classified into three types based on characteristics of the tumors: in type I, the growths are composed of air-filled pockets called cysts; in type II, the growths contain both cysts and solid tumors (or nodules); and in type III, the growths are composed solely of nodules. Types II and III are considered cancerous and can spread (metastasize), often to the brain, liver, or bones. Individuals with pleuropulmonary blastoma may develop an abnormal accumulation of air in the chest cavity that can lead to the collapse of a lung (pneumothorax).

Cystic nephroma, which involves multiple noncancerous (benign) fluid-filled cysts in the kidneys, can also occur in people with DICER1 syndrome. When associated with DICER1 syndrome, the cysts develop early in childhood and usually do not cause any health problems.

DICER1 syndrome is also associated with tumors in the ovaries known as Sertoli-Leydig tumors, which typically develop in affected women in their teens or twenties. Some Sertoli-Leydig cell tumors release the male sex hormone testosterone; in these cases, affected women may develop facial hair, a deep voice, and other male characteristics. Sertoli-Leydig tumors usually do not metastasize.

People with DICER1 syndrome are also at risk of multinodular goiter, which is enlargement of the thyroid gland caused by the growth of multiple fluid-filled or solid tumors. The tumors are generally slow-growing and benign. Despite the growths, the thyroid's function is normal. Multinodular goiter usually begins in adulthood.

How common is DICER1 syndrome?

DICER1 syndrome is a rare condition; its prevalence is unknown.

What genes are related to DICER1 syndrome?

DICER1 syndrome is caused by mutations in the DICER1 gene. This gene provides instructions for making a protein that is involved in the production of molecules called microRNA (miRNA). MicroRNA is a type of RNA, a chemical cousin of DNA, that attaches to a protein's blueprint (a molecule called messenger RNA) and blocks the production of proteins from it. Through this role in regulating the activity (expression) of genes, the Dicer protein is involved in many processes, including cell growth and division (proliferation) and the maturation of cells to take on specialized functions (differentiation).

Most of the gene mutations involved in DICER1 syndrome lead to an abnormally short Dicer protein that is likely unable to produce miRNA. Without regulation by miRNA, genes are expressed abnormally, which could cause cells to grow and divide uncontrollably and lead to tumor formation.

Related Gene(s)

Changes in this gene are associated with DICER1 syndrome.

  • DICER1

How do people inherit DICER1 syndrome?

DICER1 syndrome is inherited in an autosomal dominant pattern, which means one copy of the altered gene is sufficient to cause the disorder. It is important to note that people inherit an increased risk of tumors; most people who have mutations in the DICER1 gene do not develop abnormal growths.

Where can I find information about diagnosis or management of DICER1 syndrome?

These resources address the diagnosis or management of DICER1 syndrome and may include treatment providers.

  • Cancer.Net from the American Society of Clinical Oncology: Pleuropulmonary Blastoma--Childhood Treatment (http://www.cancer.net/cancer-types/pleuropulmonary-blastoma-childhood/treatment-options)
  • Gene Review: DICER1-Related Disorders (http://www.ncbi.nlm.nih.gov/books/NBK196157/)
  • Genetic Testing Registry: Pleuropulmonary blastoma (http://www.ncbi.nlm.nih.gov/gtr/conditions/C1266144)

You might also find information on the diagnosis or management of DICER1 syndrome in Educational resources (http://www.ghr.nlm.nih.gov/condition/dicer1-syndrome/show/Educational+resources) and Patient support (http://www.ghr.nlm.nih.gov/condition/dicer1-syndrome/show/Patient+support).

General information about the diagnosis (http://ghr.nlm.nih.gov/handbook/consult/diagnosis) and management (http://ghr.nlm.nih.gov/handbook/consult/treatment) of genetic conditions is available in the Handbook. Read more about genetic testing (http://ghr.nlm.nih.gov/handbook/testing), particularly the difference between clinical tests and research tests (http://ghr.nlm.nih.gov/handbook/testing/researchtesting).

To locate a healthcare provider, see How can I find a genetics professional in my area? (http://ghr.nlm.nih.gov/handbook/consult/findingprofessional) in the Handbook.

Where can I find additional information about DICER1 syndrome?

You may find the following resources about DICER1 syndrome helpful. These materials are written for the general public.

You may also be interested in these resources, which are designed for healthcare professionals and researchers.

What other names do people use for DICER1 syndrome?

  • DICER1-related pleuropulmonary blastoma cancer predisposition syndrome
  • pleuropulmonary blastoma familial tumor and dysplasia syndrome
  • pleuropulmonary blastoma family tumor susceptibility syndrome

For more information about naming genetic conditions, see the Genetics Home Reference Condition Naming Guidelines (http://ghr.nlm.nih.gov/ConditionNameGuide) and How are genetic conditions and genes named? (http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/naming) in the Handbook.

What if I still have specific questions about DICER1 syndrome?

Ask the Genetic and Rare Diseases Information Center (http://rarediseases.info.nih.gov/GARD/).

What glossary definitions help with understanding DICER1 syndrome?

autosomal ; autosomal dominant ; benign ; cancer ; cell ; cysts ; differentiation ; DNA ; dysplasia ; expressed ; familial ; gene ; goiter ; hormone ; inherit ; inherited ; messenger RNA ; metastasize ; molecule ; nephroma ; pleura ; pneumothorax ; population ; predisposition ; prevalence ; proliferation ; protein ; RNA ; sex hormone ; susceptibility ; syndrome ; testosterone ; thyroid ; tissue ; tumor

You may find definitions for these and many other terms in the Genetics Home Reference Glossary (http://www.ghr.nlm.nih.gov/glossary).

References

  • Bahubeshi A, Bal N, Rio Frio T, Hamel N, Pouchet C, Yilmaz A, Bouron-Dal Soglio D, Williams GM, Tischkowitz M, Priest JR, Foulkes WD. Germline DICER1 mutations and familial cystic nephroma. J Med Genet. 2010 Dec;47(12):863-6. doi: 10.1136/jmg.2010.081216. Epub 2010 Oct 29. (http://www.ncbi.nlm.nih.gov/pubmed/21036787?dopt=Abstract)
  • Foulkes WD, Bahubeshi A, Hamel N, Pasini B, Asioli S, Baynam G, Choong CS, Charles A, Frieder RP, Dishop MK, Graf N, Ekim M, Bouron-Dal Soglio D, Arseneau J, Young RH, Sabbaghian N, Srivastava A, Tischkowitz MD, Priest JR. Extending the phenotypes associated with DICER1 mutations. Hum Mutat. 2011 Dec;32(12):1381-4. doi: 10.1002/humu.21600. Epub 2011 Oct 11. (http://www.ncbi.nlm.nih.gov/pubmed/21882293?dopt=Abstract)
  • Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, Jarzembowski JA, Wikenheiser-Brokamp KA, Suarez BK, Whelan AJ, Williams G, Bracamontes D, Messinger Y, Goodfellow PJ. DICER1 mutations in familial pleuropulmonary blastoma. Science. 2009 Aug 21;325(5943):965. doi: 10.1126/science.1174334. Epub 2009 Jun 25. (http://www.ncbi.nlm.nih.gov/pubmed/19556464?dopt=Abstract)
  • Rio Frio T, Bahubeshi A, Kanellopoulou C, Hamel N, Niedziela M, Sabbaghian N, Pouchet C, Gilbert L, O'Brien PK, Serfas K, Broderick P, Houlston RS, Lesueur F, Bonora E, Muljo S, Schimke RN, Bouron-Dal Soglio D, Arseneau J, Schultz KA, Priest JR, Nguyen VH, Harach HR, Livingston DM, Foulkes WD, Tischkowitz M. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors. JAMA. 2011 Jan 5;305(1):68-77. doi: 10.1001/jama.2010.1910. (http://www.ncbi.nlm.nih.gov/pubmed/21205968?dopt=Abstract)
  • Schultz KA, Pacheco MC, Yang J, Williams GM, Messinger Y, Hill DA, Dehner LP, Priest JR. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry. Gynecol Oncol. 2011 Aug;122(2):246-50. doi: 10.1016/j.ygyno.2011.03.024. Epub 2011 Apr 17. (http://www.ncbi.nlm.nih.gov/pubmed/21501861?dopt=Abstract)
  • Slade I, Bacchelli C, Davies H, Murray A, Abbaszadeh F, Hanks S, Barfoot R, Burke A, Chisholm J, Hewitt M, Jenkinson H, King D, Morland B, Pizer B, Prescott K, Saggar A, Side L, Traunecker H, Vaidya S, Ward P, Futreal PA, Vujanic G, Nicholson AG, Sebire N, Turnbull C, Priest JR, Pritchard-Jones K, Houlston R, Stiller C, Stratton MR, Douglas J, Rahman N. DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. J Med Genet. 2011 Apr;48(4):273-8. doi: 10.1136/jmg.2010.083790. Epub 2011 Jan 25. (http://www.ncbi.nlm.nih.gov/pubmed/21266384?dopt=Abstract)

 

The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional. See How can I find a genetics professional in my area? (http://ghr.nlm.nih.gov/handbook/consult/findingprofessional) in the Handbook.

 
Reviewed: May 2013
Published: July 21, 2014